Mirenayat, M., Abedini, A., Kiani, A., Eslaminejad, A., Adimi naghan, P., Malekmohammad, M., Heshmatnia, J., Nadji, S., Idani, E., Zahiri, R., Lookzadeh, S., Sheikhzade, H., Dastan, F., Porabdollah Toutkaboni, M., Rezaei, M., Askari, E., Tabarsi, P., Marjani, M., Moniri, A., Hashemian, S., Farzanegan, B., Abtahian, Z., Yassari, F., Mansouri, S., Mansouri, S., Vasheghani, M., Mansourafshar, B., Mokhber Dezfoli, M., Soleimani, S., Seifi, S., Naghashzadeh, F., Fakharian, A., Varahram, M., Jamaati, H., Zali, A., Velayati, A. (2022). 'National Research Institute of Tuberculosis and Lung Disease (NRITLD) protocol for the treatment of patients with COVID-19', Iranian Journal of Pharmaceutical Research, (), pp. -. doi: 10.22037/ijpr.2021.115859.15565